Heart failure (HF) remains a major cause of morbidity, mortality, and increased healthcare costs worldwide, and is recognized as the result of progressive cardiovascular-kidney-metabolic (CKM) syndrome. Obesity, type 2 diabetes, chronic kidney disease, hypertension, and atherosclerotic cardiovascular disease frequently...
R. Inciardi, A. Abdin, M. Abdelhamid et al.· European Journal of Heart Fa...· 0 citations
Therapeutic developments continue to reshape HF management across the spectrum of left ventricular ejection fraction, and support the transition from a predominantly phenotype-based approach towards a more personalized and biologically informed model of HF care.
Valentino Liguori, Angelica Rizzello, M. Adamo et al.· ESC Heart Failure· 0 citations
BACKGROUND
Evidence regarding the role of N-terminal pro-brain natriuretic peptide (NTproBNP) in chronic coronary syndrome (CCS) remains limited. We aimed to investigate the association between plasma NTproBNP levels and the presence and extent of coronary artery disease (CAD) in a prospective real-world cohort.
METH...
Mirko Schivalocchi, R. Mazza, C. Gaspardone et al.· International Journal of Car...· 0 citations
An integrated, stepwise management algorithm is proposed that incorporates early risk markers, including natriuretic peptides, to guide the timing of intervention before irreversible myocardial damage occurs and enables more precise patient phenotyping and treatment tailoring.
C. Gaspardone, Paolo Costa, G. Barone et al.· Reviews in cardiovascular me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
